ZBIO: Margin operasi Zenas Biopharma, Inc.

Logo perusahaan publik Zenas Corp (ZBIO)

Zenas Biopharma Inc (ZBIO) faces significant clinical threats stemming from Obexelimab trials and the risk of a rapid cash burn. The company's revenues are based on the implementation of immunotherapy and the sale of antibodies for the treatment of kidney and thyroid diseases. A team of top immunologists is incentivized by options and grants. The operating margin trend illustrates business efficiency, while the -2747.60 metric indicates the profitability status of core operations.

Zenas Bio (ZBIO): Rentabilitas kegiatan operasi saka 14.09.2024 nganti 20.11.2026

Rincian metrik komprehensif lan analitis Zenas Biopharma Inc (ZBIO)

Analisis wiwitan perusahaan:ZBIO, zenasbio.com
Produk dadi Zenas Corp

Zenas Biopharma Inc (ZBIO) develops immunological agents whose future value depends on the therapeutic superiority of their molecules. The operating margin measures the efficiency of the core business, reflecting the share of earnings before interest and taxes. Growth in this metric signals cost optimization and pricing power. By analyzing the operating profit margin, an investor assesses the sustainability of the model. The stability of this operating profit margin confirms the fundamental viability of the company.

Pesaing Zenas Biopharma Inc

ARGX (argenx N.V.) - Margin operasi|Rentabilitas dodolan operasi BioNTech Pharma BNTX|Margin dodolan operasi ABVX (ABIVAX)|Margin operasi ADMA Biologics, Inc. (ADMA)|Margin operasi PTGX (protagonist-inc.com)|IMVT: Rentabilitas dodolan miturut bathi operasi|KNSA - Rentabilitas operasi|GRFS: Rentabilitas operasi|ADPT (Adaptive Biotechnologies) - Margin dodolan operasi|Rentabilitas dodolan miturut bathi operasi CLDX|Margin dodolan operasi AUPH|BCRX (BioCryst Pharmaceuticals) - Rasio bathi operasi|Rentabilitas operasi Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Tingkat bathi operasi|Pharvaris N.V. - Margin dodolan operasi|Tingkat bathi operasi ABCL|TRML: Margin dodolan operasi|PGEN (Precigen) - Rentabilitas dodolan miturut bathi operasi|pharming.com (PHAR) - Rentabilitas operasi|Nektar Corp (NKTR) - Margin operasi|UPB (upstreambio.com) - Margin operasi|Immunome, Inc. (IMNM) - Rentabilitas kegiatan operasi|Margin operasi GOSS|Margin dodolan operasi KalVista Pharmaceuticals, Inc. KALV|Rentabilitas operasi Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Rentabilitas dodolan operasi|SVRA - Rentabilitas operasi|Rigel Pharmaceuticals - Rasio bathi operasi|AnaptysBio Corp (ANAB) - Rentabilitas operasi|ATXS - Rentabilitas kegiatan operasi|Rentabilitas operasi enGene Holdings Inc.|RAPT: Tingkat bathi operasi|Margin operasi JBIO|Margin dodolan operasi aclaristx.com ACRS|Rentabilitas operasi Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Rentabilitas dodolan operasi|Cabaletta Bio, Inc - Margin operasi|Rentabilitas dodolan operasi Ventyx Biosciences|THTX (theratech.com) - Margin dodolan operasi|Margin dodolan operasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Margin operasi|Rentabilitas dodolan operasi Agenus Inc. AGEN|Margin dodolan operasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Tingkat bathi operasi|Rentabilitas operasi atyrpharma.com ATYR|Margin operasi Adagene Corp ADAG|IMA - Rentabilitas operasi|Tingkat bathi operasi STTK (Shattuck Labs)|EQ: Margin operasi|Connect Biopharma (CNTB) - Margin operasi|Rentabilitas operasi Immunic|Margin operasi atarabio.com|Margin operasi IFRX|Margin operasi X4 Pharma (XFOR)|Margin operasi ACET (adicetbio.com)|Margin operasi Celularity Inc. CELU|INMB - Rentabilitas operasi|Tingkat bathi operasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Margin dodolan operasi|Margin dodolan operasi SAB Biotherapeutics Inc.|Margin dodolan operasi AKTX|Margin dodolan operasi enlivex.com (ENLV)|Rentabilitas operasi Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Tingkat bathi adhedhasar bathi operasi|Margin operasi EDSA (Edesa Biotech Corp)|Rentabilitas kegiatan operasi iBio (IBIO)|CARM - Rentabilitas operasi|XTL Biopharmaceuticals (XTLB) - Margin dodolan operasi|BOLT: Margin operasi|Margin dodolan operasi HCW Biologics Inc.|Rentabilitas operasi Aptevo|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com